These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Thyrotropin-secreting pituitary adenomas: clinical and biochemical heterogeneity. Case reports and follow-up of nine patients. Gesundheit N; Petrick PA; Nissim M; Dahlberg PA; Doppman JL; Emerson CH; Braverman LE; Oldfield EH; Weintraub BD Ann Intern Med; 1989 Nov; 111(10):827-35. PubMed ID: 2479309 [TBL] [Abstract][Full Text] [Related]
3. Surgical Outcome and Treatment of Thyrotropin-Secreting Pituitary Tumors in a Tertiary Referral Center. Herguido NG; Fuentes ED; Venegas-Moreno E; Maorad LB; Flores-Martinez A; Ruiz PR; Dueñas MC; Roldán F; Fajardo E; Ruiz-Valdepeñas EC; Kaen A; Martín Schrader I; Cano DA; Soto-Moreno A World Neurosurg; 2019 Oct; 130():e634-e639. PubMed ID: 31276853 [TBL] [Abstract][Full Text] [Related]
4. Ectopic thyrotropin secreting pituitary adenoma concomitant with papillary thyroid carcinoma: Case report. Yang J; Liu S; Yang Z; Shi YB Medicine (Baltimore); 2017 Dec; 96(50):e8912. PubMed ID: 29390279 [TBL] [Abstract][Full Text] [Related]
6. Surgical management of thyrotropin-secreting pituitary adenomas. Losa M; Mortini P; Franzin A; Barzaghi R; Mandelli C; Giovanelli M Pituitary; 1999 Aug; 2(2):127-31. PubMed ID: 11081163 [TBL] [Abstract][Full Text] [Related]
7. Hyperthyroidism and acromegaly due to a thyrotropin- and growth hormone-secreting pituitary tumor. Lack of hormonal response to bromocriptine. Carlson HE; Linfoot JA; Braunstein GD; Kovacs K; Young RT Am J Med; 1983 May; 74(5):915-23. PubMed ID: 6340497 [TBL] [Abstract][Full Text] [Related]
8. Clinicopathological characteristics and therapeutic outcomes in thyrotropin-secreting pituitary adenomas: a single-center study of 90 cases. Yamada S; Fukuhara N; Horiguchi K; Yamaguchi-Okada M; Nishioka H; Takeshita A; Takeuchi Y; Ito J; Inoshita N J Neurosurg; 2014 Dec; 121(6):1462-73. PubMed ID: 25237847 [TBL] [Abstract][Full Text] [Related]
9. Thyrotropin-secreting pituitary adenomas. Clinical and biological heterogeneity and current treatment. Sanno N; Teramoto A; Osamura RY J Neurooncol; 2001 Sep; 54(2):179-86. PubMed ID: 11761434 [TBL] [Abstract][Full Text] [Related]
10. Criteria of cure and follow-up of central hyperthyroidism due to thyrotropin-secreting pituitary adenomas. Losa M; Giovanelli M; Persani L; Mortini P; Faglia G; Beck-Peccoz P J Clin Endocrinol Metab; 1996 Aug; 81(8):3084-90. PubMed ID: 8768879 [TBL] [Abstract][Full Text] [Related]
11. Long-term surgical outcome in 16 patients with thyrotropin pituitary adenoma. Sanno N; Teramoto A; Osamura RY J Neurosurg; 2000 Aug; 93(2):194-200. PubMed ID: 10930003 [TBL] [Abstract][Full Text] [Related]
19. Ectopic Suprasellar Thyrotropin-Secreting Pituitary Adenoma: Case Report and Literature Review. Wang Q; Lu XJ; Sun J; Wang J; Huang CY; Wu ZF World Neurosurg; 2016 Nov; 95():617.e13-617.e18. PubMed ID: 27567574 [TBL] [Abstract][Full Text] [Related]
20. Primary Medical Treatment of Thyrotropin-Secreting Pituitary Adenomas by First-Generation Somatostatin Analogs: A Case Study of Seven Patients. Rimareix F; Grunenwald S; Vezzosi D; Rivière LD; Bennet A; Caron P Thyroid; 2015 Aug; 25(8):877-82. PubMed ID: 26244412 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]